Aclaris Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aclaris Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.11 | $-0.01 | -1000.0 % |
Jun 2024 | 2024-08-07 | $-0.15 | $-0.20 | 25.0 % |
Mar 2024 | 2024-05-07 | $-0.24 | $-0.29 | 17.2 % |
Dec 2023 | 2024-02-27 | $-0.30 | $-0.34 | 11.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $4.35M | $7.12M | -39.0 % |
Jun 2024 | 2024-08-07 | $2.77M | $1.82M | 52.0 % |
Mar 2024 | 2024-05-07 | $2.40M | $1.37M | 75.0 % |
Dec 2023 | 2024-02-27 | $17.57M | $3.36M | 422.9 % |
Aclaris Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
Aclaris Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-0.11, which missed the estimate of $-0.01.
Aclaris Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.